BFLY
Butterfly Network, Inc.
NYSE · Healthcare · Medical - Devices · US
$7.36
+0.96%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 112.1M | 97.6M | 82.1M | 65.9M | 73.4M |
| Cost of Revenue | 53.1M | 51.9M | 33.2M | 49.0M | 33.9M |
| Gross Profit | 59.0M | 45.7M | 48.8M | 16.9M | 39.5M |
| Operating Expenses | |||||
| R&D Expense | 38.1M | 36.3M | 37.8M | 55.6M | 88.0M |
| SG&A Expense | 92.2M | 85.1M | 85.4M | 106.8M | 144.4M |
| General & Admin Expense | 46.3M | 39.2M | 43.9M | 67.8M | 84.9M |
| Selling & Marketing Expense | 45.9M | 45.9M | 41.6M | 39.1M | 59.5M |
| Other Expenses | 8.1M | 10.8M | — | — | — |
| Total Operating Expenses | 138.4M | 132.1M | 123.2M | 162.5M | 232.5M |
| Cost and Expenses | 191.5M | 184.0M | 156.5M | 211.5M | 266.4M |
| Operating Income (EBIT) | (79.4M) | (86.4M) | (74.4M) | (145.6M) | (193.0M) |
| Non-Operating | |||||
| Interest Income | 5.0M | 5.9M | 5.0M | 7.5M | 3.4M |
| Interest Expense | 1.3M | 1.5M | 1.3M | — | 2.0K |
| Net Interest Income | 3.7M | 4.4M | 3.8M | 7.5M | 3.4M |
| Other Non-Op Income/Expense | 4.6M | 9.5M | 1.9M | 12.0M | 24.3M |
| Non-Operating Income (excl Interest) | (6.0M) | (11.0M) | (3.1M) | (12.0M) | (24.3M) |
| EBT (Pre-Tax Income) | (74.8M) | (77.0M) | (72.5M) | (133.6M) | (168.7M) |
| Income Tax Expense | 82.0K | 110.0K | (32.0K) | 82.0K | 42.0K |
| Bottom Line | |||||
| Net Income | (74.8M) | (77.1M) | (72.5M) | (133.7M) | (168.7M) |
| Earnings from Cont. Ops | (74.8M) | (77.1M) | (72.5M) | (133.7M) | (168.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (74.8M) | (77.1M) | (72.5M) | (133.7M) | (168.7M) |
| Per Share | |||||
| Basic EPS | ($0.29) | ($0.31) | ($0.34) | ($0.65) | ($0.84) |
| Diluted EPS | ($0.29) | ($0.31) | ($0.34) | ($0.65) | ($0.84) |
| Revenue Per Share | $0.43 | $0.39 | $0.39 | $0.32 | $0.37 |
| Shares | |||||
| Basic Shares Outstanding | 262.1M | 247.1M | 211.7M | 205.4M | 199.8M |
| Diluted Shares Outstanding | 262.1M | 247.1M | 211.7M | 205.4M | 199.8M |
| Profitability Metrics | |||||
| EBITDA | (66.3M) | (67.4M) | (60.9M) | (123.0M) | (162.7M) |
| D&A | 7.1M | 8.1M | 10.3M | 10.6M | 5.9M |
| EBIT | (73.4M) | (75.5M) | (71.3M) | (133.6M) | (168.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026